Concepedia

Akhtar Ashfaq

AA

Statistics

Publications

15

Citations

418

H-Index

12

Active since

2013

Affiliations

OPKO Health (United States)(Current)

University of Minnesota

Hennepin Healthcare Research Institute

Amgen (United States)

Vifor Pharma (Switzerland)

Akhtar Ashfaq is an author at OPKO Health (United States) specializing in medicine, nephrology, and chronic kidney disease.

ORCID

Publications per year

2013–2025

15

Publications

15

Rationale for Raising Current Clinical Practice Guideline Target for Serum 25-Hydroxyvitamin D in Chronic Kidney Disease

Stephen A. Strugnell, Stuart M. Sprague, Akhtar Ashfaq et al. · American Journal of Nephrology · 2019 · 70 citations

, , +17

Epoetin Alfa and Outcomes in Dialysis amid Regulatory and Payment Reform

Glenn M. Chertow, Jiannong Liu, Keri L. Monda et al. · Journal of the American Society of Nephrology · 2016 · 59 citations · Full text

, , +17

Epidemiology and health outcomes associated with hyperkalemia in a primary care setting in England

Laura Horne, Akhtar Ashfaq, Sharon MacLachlan et al. · BMC Nephrology · 2019 · 41 citations · Full text

, , +13

Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, Amr E. Abbas, Fatima Abbas et al. · The Lancet Diabetes & Endocrinology · 2023 · 40 citations · Full text

, , +11

Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial

Saul N. Faust, Richard Haynes, Christine E. Jones et al. · The Lancet Child & Adolescent Health · 2024 · 38 citations · Full text

, , +15

1–5 of 15